Research Operations
Improving Access to Research for Diverse and Underserved Populations
Increasing diversity and inclusion in research has long been a challenge in the clinical research community. Learn strategies to increase access to clinical trials for all.
Industry-Wide Solutions to Improve Access to Clinical Trials
In this discussion, panelists provide actionable strategies for improving access to clinical research for diverse, underserved populations.
Pitfalls of Chemistry, Manufacturing, and Controls in Investigational New Drug Preparation
Submitting an Investigational New Drug (IND) application for the first time? Consider three common CMC pitfalls that may impact submission.
The Current State of Study Activation and Methods to Ensure Success
This webinar will discuss the importance of protocol feasibility and identifying solutions to ensure your organization's success.
The State of Clinical Trial Activation at Sites
While the study activation process is necessary for all sites to conduct, efficiently coordinating all necessary aspects can be challenging.
Regulatory Fine Points: What Research Sites Need to Do for Part 11 Compliance
Summary of James Riddle's Presentation at SQA, which outlines considerations for sponsors when ensuring 21 CFR Part 11 compliance at sites.
How to Be Research Ready: Today and Beyond
If presented with a new study, are you prepared to take it on? Efficient study activation can set the pace for a successful clinical trial.
World’s Largest CRO Leverages Partnership With Integrated Central IBC to Initiate Sites in COVID-19 Vaccine Research at Warp Speed
Advarra’s IRB and IBC reviews and Gene Therapy Ready site network helped reduce study startup timelines and delivered trial results to the sponsor quicker than expected.
Building a Foundation for Regulatory Success in the Post-Pandemic Landscape
Read how an eRegulatory system can increase productivity, improve compliance, and ensure a return on your technology investment.
What is Coverage Analysis in Clinical Research?
This infographic outlines the importance of coverage analysis, consequences to non-compliance, and solutions to avoid non-compliance.
BBK Worldwide Features Advarra Executive Michele Russell-Einhorn in Diversity and Inclusion Video
This video discusses methods IRBs can implement to increase diversity and inclusion among trial participants.
Q&A: FDA Inspections of Clinical Investigators: Understanding the Process and What to Expect
Q&A from our 4/21 webinar outlining what to expect in an FDA inspection and how to have a more positive experience.